Liver Failure, Cirrhosis and Varices

Acute Liver Failure: Presentation, Neurological Crises, and Metabolic Stability

Acute liver failure is a catastrophic clinical syndrome defined by the rapid onset of coagulopathy, marked by an international normalized ratio (INR) of 1.5 or greater, alongside hepatic encephalopathy within 26 weeks of the initial liver insult in an individual without preexisting cirrhosis. In the United States, acetaminophen toxicity represents the leading cause of this acute breakdown. When acetaminophen toxicity is known or suspected, the nurse promptly administers provider-ordered N-acetylcysteine under established protocols; it replenishes hepatic glutathione early in toxicity and can improve outcomes even after liver injury is established, but does not necessarily halt hepatocyte injury.

A failing liver cannot effectively process systemic waste, leading to hyperammonemia. Ammonia crosses into the central nervous system where it contributes directly to hepatic encephalopathy and drives astrocyte swelling, creating severe cerebral edema. However, bedside nurses must recognize that laboratory serum ammonia levels do not consistently correlate with the clinical stage or severity of encephalopathy. In patients who deteriorate into grade III or IV encephalopathy, cerebral edema and life-threatening intracranial hypertension become paramount threats.

Managing intracranial pressure requires dedicated neuroprotective nursing interventions. Nurses must keep the head of the bed elevated to 30 degrees, position the patient's neck in a neutral midline alignment to promote cerebral venous drainage, and strictly minimize noxious stimuli. Under protocol or provider orders, hypertonic saline may be administered to maintain a targeted serum sodium of approximately 145 to 155 mEq/L, which requires continuous neurological assessments and frequent sodium checks. When renal replacement therapy is indicated in acute liver failure, particularly with cerebral edema or intracranial hypertension, continuous renal replacement therapy is generally preferred over intermittent hemodialysis because its slower fluid and solute shifts reduce the risk of intracranial pressure increases.

Metabolic instability further complicates acute liver failure. Because hepatic gluconeogenesis is severely impaired and glycogen stores are rapidly depleted, patients are at immediate risk for life-threatening hypoglycemia, demanding frequent blood glucose monitoring and timely dextrose infusions per protocol or provider orders. Furthermore, nurses frequently encounter elevated serum lactate levels. Rather than assuming elevated lactate indicates sepsis alone, the nurse must consider that it reflects impaired hepatic clearance of lactate, peripheral tissue hypoperfusion, or both, necessitating careful correlation with systemic perfusion trends.